CXCL5 overexpression is associated with late stage gastric cancer

Journal of Cancer Research and Clinical Oncology

Volumn 133, Issue 11, 2007, Pages 835-840

  Park, Jeong Youp ^a   Park, Kyung Hwa ^a   Bang, Seungmin ^a   Kim, Myoung Hwan ^a   Lee, Ji Eun ^a   Gang, Jingu ^a   Koh, Sang Seok ^b   Song, Si Young ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Chemokine; CXCL5; Gastric cancer; Lymph node metastasis

Indexed keywords

BLOOD CLOTTING FACTOR 8; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; MONOCLONAL ANTIBODY;

ADULT; ANALYTIC METHOD; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRECTOMY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; STOMACH CANCER; TISSUE MICROARRAY; UPREGULATION;

CARCINOMA, SIGNET RING CELL; CHEMOKINE CXCL5; FEMALE; GASTRECTOMY; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 36849002924     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0225-x     Document Type: Article

References (36)

1. Abe S, Ogawa Y, Nagasue N, Sasaki Y, Akamizu H, Hirose S, Yukaya H, Suehiro S (1984) Early gastric cancer: results in a general hospital in Japan. World J Surg 8:308-314
2. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM (1996) Inhibition of interleukin-8 reduces tumorigensis of human non-small cell lung cancer. J Clin Invest 97:2792-2802
3. Arenberg DA, Keane MP, DiGiovine B, Kunkel SL, Morris SB, Xue YY, Burdick MD, Glass MC, Iannettoni MD, Strieter RM (1998) Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 102:465-472
4. Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A, Maysushima K, Murphy P, Nomiyama H, Oppenheim J, Rot A, Schall T, Tsang M, Thorpe R, Van Damme J, Wadhwa M, Yoshie O, Zlotnik A, Zoon K; IUIS/WHO Subcommittee on Chemokine Nomenclature (2002) Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 22:1067-1068
5. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540-550
6. Bonacchi A, Romagnani P, Romanelli RG, Efsen E, Annunziato F, Lasagni L, Francalanci M, Serio M, Laffi G, Pinzani M, Gentilini P, Marra F (2001) Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 276:9945-9954
7. Caruso RA, Bellocco R, Pagano M, Bertoloi G, Riogoli L, Inferrera C (2002) Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Modern Pathol 15:831-837
8. Cenitagoya GF, Bergh CK, Klinger-Roitman J (1998) A prospective study of gastric cancer. Real 5-year survival rates and mortality rates in a country with high incidence. Dig Surg 15:317-322
9. Chandrasekar B, Melby PC, Sarau HM, Raveendran M, Perla RP, Marelli-Berg FM, Dulin NO, Singh IS (2003) Chemokine-Cytokine Cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-nB pathway. J Biol Chem 278:4675-4686
10. Chandrasekar B, Bysani S, Mummidi S (2004) CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, InB kinase, and nuclear factor-nB and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem 279:3188-3196
11. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Strieter RM (1995) Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. J Clin Invest 95:134-141
12. De Larco JE, Wuertz BR, Furcht LT (2004) The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 10:4895-4900
13. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P (2001) The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97:339-345
14. Fidler IJ (2002) Critical determinants of metastasis. Semin Cancer Biol 12:89-96
15. Hundahl AS, Phillips JL, Menck HR (2000) The National Cancer Data Base report on poor survival of US gastric carcinoma patients treated with gastrectomy: fifth edition American Joint Committee on cancer staging, proximal disease, and the ''different disease'' hypothesis. Cancer 88:921-932
16. Hyung WJ, Noh SH, Yoo CH, Huh JH, Shin DW, Lah KH, Lee JH, Choi SH, Min JS (2002) Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 26:323-329
17. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF (2003) Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 21:3647-3650
18. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ (1998) Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-1 and Kupffer cells. Hepatology 27:507-512
19. Miyazaki H, Patel V, Wang H, Edmunds RK, Gutkind JS, Yeudall WA (2006) Down-regulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res 66:4279-4284
20. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56
21. Nagata T, Ikeda M, Nakayama F (1983) Changing state of gastric cancer in Japan: histologic perspectives of the past 76 years. Am J Surg 145:226-233
22. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37:S4-S66
23. Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, Jeffery PK (2003) Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Resp Crit Care 168:968-975
24. Ridley AJ (2001) Rho GTPases and cell migration. J Cell Sci 114:2713-2722
25. Schraufstatter IU, Chung J, Burger M (2001) IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 280:L1094-L1103
26. Shimoyama T, Everett SM, Dixon MF, Axon AT, Crabtree JE (1998) Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol 1998 51:765-770
27. Sieveking D, Mitchell HM, Day AS (2004) Gastric epithelial cell CXC chemokine secretion following Helicobacter pylori infection in vitro. J Gastroenterol Hepatol 19:982-987
28. Suzuki H, Mori M, Sakaguchi AA, Suzuki M, Miura S, Ishii H (1998) Enhanced levels of C-X-C chemokine, human GROalpha, in Helicobacter pylori-associated gastric disease. J Gastroenterol Hepatol 13:516-520
29. Venkatakrishnan G, Salgia R, Groopman JE (2000) Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 275:6868-6875
30. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM (1991) Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. J Exp Med 174:1355-1362
31. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R (1993) Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 218:583-592
32. Wang D, Sai J, Carter G, Sachpatzidis A, Lolis E, Richmond A (2002) PAK1 kinase is required for CXCL1-induced chemotaxis. Biochemistry 41:7100-7107
33. Welch DR, Scissel DJ, Howrey RP, Aeed PA (1989) Tumor-elicited polymorphonuclear cells, contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. P Natl Acad Sci USA 86:5859-5863
34. White ES, Flaherty KR, Carskadon S, Brant A, Iannettoni MD, Yee J, Orringer MB, Arenberg DA (2003) Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res 9:853-860
35. Wulfing P, Kersting C, Tio J, Fischer RJ, Wulfing C, Poremba C, Diallo R, Bocker W, Kiesel L (2004) Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. Clin Cancer Res 10:2393-2400
36. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121-127